Omni is a Michigan based physician-owned PLLC with eight years’ experience in providing medical cannabis evaluations to over 30,000 patients and currently has clinic locations in five states including Michigan, Ohio, Illinois, Pennsylvania, and Florida.  Omni offers its CBD products at its clinic locations and by direct mailing to all 50 states. 

Omni’s CEO David Koyle states “With our extensive experience in patient care, we’ve decided to produce a new line of products that we feel will benefit our patients the most.”  

We’re already a trusted source with our patients said Koyle, so we’re very pleased to sign this joint venture partnership with NutraLife Biosciences whose goal of offering a superior product parallels Omni’s.

Omni’s first products are 1,000 mg full spectrum spray tinctures and 500 mg topical lotions with an official launch planned in January 2020. Additional product lines scheduled for Q1 include edibles and topicals with higher concentrations and a wide variety of  terpenes Koyle adds “we reviewed the market for over a year and chose NutraLife Biosciences with its excellent track record and state-of-the-art manufacturing capabilities as well as being vertically integrated from seed to sale including superior hemp strains and extraction processing methods.

As part of launching its new line of CBD products, Omni plans further research with its patients to advance DNA testing that provides personalized profiles for the best CBD strains specifically for individual patients. The aim is to discover the precise CBD strains maximized for each patient.

First up for retail stores, Omni has recently signed an agreement to sell its products at Charlotte CBD stores with three retail locations in North and South Carolina. 

NutraLife BioSciences, Inc. is an SEC reporting company on the OTC trading with the symbol NLBS, NLBS was founded in 2010.  NutraLife is a Florida based FDA registered manufacturer of a wide range of life science products that include seventeen (17) different core formulations with over 50 different variations.



At CBD Solutions, you won’t only find what you need; you’ll get the true CBD quality at a fair price.


With years of experience in the industry, we have the expertise to thoroughly and efficiently serve our customers to ensure they’re never disappointed.

Whether you’re a one-time buyer or looking to buy in bulk, you can count on us to provide great products and excellent service, every step of the way.



  • Dr. Recommended - Physician Approved

  • FDA Registered Processing & Manufacturing

  • Seed to Sale - Farm to Table Solutions

  • USA Cultivated and Harvested High CBD Hemp Farms

  • Fair Pricing - No Sales Pitch

  • Fast Direct Shipping - Legal in 50 States

  • 100% Satisfaction Policy - Easy Returns


United States Farm Bill ​- THC FREE 

The United State Farm Bill descheduled some cannabis products from the Controlled Substances Act for the first time.  The U.S. Farm Bill established a new federal hemp regulatory system under the US Department of Agriculture which aims to facilitate the commercial cultivation,


  • removes hemp & hemp seeds from the statutory definition of marijuana

  • removes hemp & hemp seeds from the DEA schedule of Controlled Substances.

  • makes hemp an eligible crop under the federal crop insurance program.

  • also allows the transfer of hemp and hemp-derived products across state lines provided the hemp was lawfully produced under a State or Indian Tribal plan or under a license issued under the USDA plan.

  • OMNI CBD SOlutions abide by the US Farm Bill guidlines.

thc free.png


The Hemp Farming Act of 2018 was a proposed law to remove hemp (defined as cannabis with less than 0.3% THC) from Schedule I controlled substances and making it an ordinary agricultural commodity. Its provisions were incorporated in the 2018 United States farm bill that became law on December 20, 2018.